Stratrix
On the Record · Donaldson

Donaldson acquisitions, on the record

The businesses Donaldson bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

BusinessDealWhenValue
Univercells Technologies (UTEC)
Word for word“In the fourth quarter of fiscal 2023, the Company acquired UTEC, headquartered in Nivelles, Belgium, for cash consideration of € 134.6 million, or $ 147.2 million, net of cash acquired.” 10-K for 2024
acquisitionIn the fourth quarter of fiscal 2023€ 134.6 million, or $ 147.2 million, net of cash acquired
Isolere Bio, Inc. (Isolere)
Word for word“In the third quarter of fiscal 2023, the Company acquired Isolere, headquartered in Durham, North Carolina, for cash consideration of $ 62.4 million, net of cash acquired.” 10-K for 2024
acquisitionIn the third quarter of fiscal 2023$ 62.4 million, net of cash acquired
Solaris Biotechnology S.r.l. (Solaris)
Word for word“In the second quarter of fiscal 2022, the Company acquired Solaris, headquartered in Porto Mantovano, Italy, with U.S. operations based in Berkeley, California, for cash consideration of approximately € 41 million, or $ 45.7 million, net of cash acquired.” 10-K for 2024
acquisitionIn the second quarter of fiscal 2022approximately € 41 million, or $ 45.7 million, net of cash acquired
Purilogics, LLC (Purilogics)
Word for word“In the fourth quarter of fiscal 2022, the Company acquired Purilogics, headquartered in Greenville, South Carolina, for cash consideration of approximately $ 19.9 million, net of cash acquired.” 10-K for 2024
acquisitionIn the fourth quarter of fiscal 2022approximately $ 19.9 million, net of cash acquired
Pearson Arnold Industrial Services (PAIS)
Word for word“In the second quarter of fiscal 2022, the Company acquired PAIS, headquartered in the U.S., for cash consideration of approximately $ 3.3 million, net of cash acquired.” 10-K for 2024
acquisitionIn the second quarter of fiscal 2022approximately $ 3.3 million, net of cash acquired
Medica S.p.A. (Medica) 49% non-controlling stake
Word for word“Subsequent to year end, on August 9, 2024, the Company acquired a 49 % non-controlling stake in Medica S.p.A. (Medica), headquartered in Medolla, Italy, for cash consideration of approximately € 62 million, or $ 68 million.” 10-K for 2024
acquisitionSubsequent to year end, on August 9, 2024approximately € 62 million, or $ 68 million
Isolere Bio, Inc. and Univercells Technologies (UTEC)
Word for word“In fiscal year 2023, Donaldson acquired Isolere Bio, Inc. (Isolere), headquartered in Durham, North Carolina and Univercells Technologies (UTEC), headquartered in Nivelles, Belgium.” 10-K for 2025
acquisitionfiscal year 2023—
Solaris Biotechnology S.r.l. and Purilogics LLC
Word for word“During fiscal year 2022, the Company acquired Solaris Biotechnology S.r.l. (Solaris), headquartered in Porto Mantovano, Italy and Purilogics LLC (Purilogics) headquartered in Greenville, South Carolina.” 10-K for 2025
acquisitionfiscal year 2022—
Filtration Group’s Facet Filtration business (Facet), consisting of Facet (Oklahoma) LLC and Facet Netherlands B.V.
Word for word“On May 4, 2026, the Company acquired 100 % of Filtration Group’s Facet Filtration business (Facet), consisting of Facet (Oklahoma) LLC and Facet Netherlands B.V., in an all-cash transaction valued at $ 820.0 million, for cash consideration of $ 830.2 million.” 10-K for 2026
acquisitionOn May 4, 2026$ 820.0 million
As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year endedCash paid for acquisitions (net of cash acquired)Goodwill from acquisitions
2016-07-31$12.9 million$6.3 million
2017-07-31$32.2 million$6.7 million
2018-07-31−$500,000$600,000
2019-07-31$96 million$72.9 million
2020-07-31$6.5 million$5.4 million
2021-07-31$0$0
2022-07-31$68.9 million$42.8 million
2023-07-31$209.2 million$125.1 million
2024-07-31$2 million$1.9 million
2025-07-31$2.4 million$3.2 million

Deal filings since 2016

Read from Donaldson’s annual reports (10-K for 2026, 10-K for 2025, 10-K for 2024) and the financial data it files with the SEC, as of 2026-09-25. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.